Multiple myeloma (MM) cells are responsible for aberrant osteoclast (OC) activation. However, when cocultured monocytes, but not OC precursors, with MM cells, we made a novel observation that MM cells inhibited receptor activator of nuclear factor κB ligand (RANKL)-induced increase of OC differentiation, OC gene expression, signaling pathways and bone resorption activity. Our results showed that MM cells produced multiple inhibitory cytokines of osteoclastogenesis, such as IL-10, which activated STAT3 signaling and induce OC inhibition. However, cocultures of bone marrow stromal cells (BMSCs) reversed MM-induced OC inhibition. We found that MM cells increased production of MCP-1 from BMSCs and BMSC-derived MCP-1 enhanced OC formation. Mechanistic studies showed that IL-10 downregulated RANK expression in monocytes and thus, inhibited RANKL-induced OC formation. In contrast, MCP-1 upregulated RANK expression and thus, enhanced OC formation. Overall, our studies for the first time demonstrated that MM cell have inhibitory effects on osteoclastogenesis by producing inhibitory cytokines. Our results further indicate that activation of osteoclastogenesis in bone marrow requests the crosstalk of MM cells, BMSCs and their produced cytokines. Thus, our studies provide evidences that targeting bone marrow microenvironmental cells and/or cytokines may be a new approach to treating MM bone destruction.
Introduction
Bone is a dynamic tissue that undergoes resorption and formation. Osteoclast (OC)-mediated bone resorption is crucial for normal bone homeostasis, and also plays a causative role in osteoporosis, rheumatoid arthritis, Paget disease, multiple myeloma (MM), and bone metastasis of breast cancers [1] [2] [3] . OCs, which are essentially effector cells for resorbing bone tissue, arise from hematopoietic monocytic precursors within the bone marrow cavity [4, 5] . During OC differentiation, associated genes such as those for tartrate-resistant acid phosphatase (TRAP), calcitonin-related polypeptide alpha (CALCA) and CALCA receptor (CALCR), cathepsin K (CTSK), β3-integrin, and ATP-dependent proton pump subunit 18 are encoded and expressed [6, 7] . Mature OCs can polarize and adhere to bone matrix, induce actin ring formation, acidify bone surface, and release osteolytic enzymes to resorb bone tissue [8] . Recent studies showed that multiple cytokines and chemokines, produced primarily by bone marrow stromal cells (BMSCs), osteoblasts, and activated immune cells, regulate osteoclastogenesis [9] . For example, receptor activator of nuclear factor kappa-B (NF-κB) ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) activate OC differentiation and bone resorption activity, while RANKL decoy receptor osteoprotegerin (OPG) inhibits RANKL effects [10] .
Bone destruction is a hallmark of MM. More than 80% of patients with MM develop osteolytic bone destruction that causes pathological fractures, bone pain, and hypercalcemia [11, 12] . Recent studies showed that MM cells are responsible for activation of osteoclastogenesis. MM cells upregulate RANKL production and downregulate OPG production from BMSCs [13, 14] . Moreover, MM cells express and release RANKL to the microenvironment. Increased RANKL levels and decreased OPG levels disrupt OPG/RANKL balance and induce enhanced OC differentiation and bone resorption activity [15] [16] [17] . MM cells also express multiple cytokines and chemokines, such as interleukin (IL)-3, IL-7, monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, and parathyroid hormonerelated protein (PTHrP), all of which enhance OC differentiation and activity in a RANKL-dependent or -independent manner [18] . Furthermore, cocultures of MM cells have been shown to induce mature OC formation from monocyte-derived OC precursors (preOCs) [19] . However, the mechanism underlying increased OC differentiation and activity induced by MM cells remains unclear. In this study, we demonstrate for the first time that cocultures with MM cells inhibit RANKL-induced OC differentiation from monocytes but not from preOCs, and elucidate a novel mechanism whereby bone marrow osteoclastogenesis is influenced by crosstalk between MM cells, BMSCs, and derived cytokines.
Materials and Methods

Antibodies and reagents
Neutralization antibodies against IL-10, MCP-1, control immunoglobulin G (IgG), and recombinant human M-CSF and RANKL were purchased from R&D Systems (Minneapolis, MN). Western blot antibodies against phosphorylated or nonphosphorylated NF-κB, ERK, JNK, p38MAPK and STAT3 were purchased from Cell Signaling Technology (Danvers, MA). Antibodies against RANK were purchased from eBioscience (San Diego, CA).
MM cell lines and primary MM cells
MM cell lines ARP-1 and ARK were kindly provided by the Arkansas Cancer Research Center, Little Rock, AR. Other cell lines were purchased from the American Type Culture Collection (Rockville, MD). Primary MM cells were isolated at the University of Texas MD Anderson Cancer Center from bone marrow aspirates of MM patients during routine clinic visits by using anti-CD138 monoclonal antibody-coated magnetic beads (Miltenyi Biotec GmbH, Auburn, CA). The study was approved by the Institutional Review Board of MD Anderson Cancer Center. All human participants provided written informed consent. All MM cells were cultured in RPMI 1640 medium (Mediatech Cellgro, VA) supplemented with 10% fetal bovine serum (FBS) and antibiotics.
Cells cultures, cocultures, and functional assay of OCs
The method for generating OCs in vitro has been described previously [20] . Briefly, peripheral blood mononuclear cells (PBMCs) were obtained from healthy donor buffy coats (Gulf Coast Regional Blood Center, TX) by Ficoll-Paque (GE Healthcare, WI) density gradient centrifugation. Monocytes were isolated from the PBMCs by using anti-CD14 antibodycoated magnetic beads (Miltenyi Biotec GmbH, Auburn, CA) and cultured in α-MEM medium supplemented with 10% FBS, antibiotics, and 25 ng/mL of human M-CSF for 7 days to obtain TRAP + mononuclear cells (as preOCs). PreOCs were then cultured in medium with M-CSF (25 ng/mL) and RANKL (50 ng/mL) for another 7 days to obtain multinuclear (>3 nuclei) TRAP + mature OCs. The numbers of multinuclear TRAP + OCs per well of 24-well plate were counted.
In cocultures, CD14 + monocytes (5 × 10 5 /mL) were seeded in culture wells, and MM cells (2 × 10 5 /mL) were coseeded in culture wells or separately seeded in transwell inserts. In some cocultures, BMSCs (5 × 10 5 /mL) were also coseeded with MM cells in transwell inserts. Cells were cultured in M-CSFcontaining medium with or without RANKL for 14 days. BMSCs were generated from the bone marrow aspirates of MM patients or healthy donors or were generated from human healthy fetal bones in DMEM medium supplemented with 10% FBS and antibiotics [21] .
TRAP staining for detection of mature OCs was performed with the Leukocyte Acid Phosphatase kit (Sigma-Aldrich, MO) according to the manufacturer's instructions. Quantitative measurement of active isoform TRAP 5b was done using BoneTRAP® Assay (Immunodiagnostic Systems Inc., Scottsdale, AZ) according to the manufacturer's instructions.
Quantitative real-time PCR
Total RNA was isolated with the RNeasy kit (Qiagen, MD). An aliquot of 1 μg of total RNA was subjected to reverse transcription with SuperScript II RT PCR kit (Invitrogen, CA). 1 μL of the final cDNA was applied to real-time PCR amplification with SYBR Green using the StepOnePlus real-time PCR system (Invitrogen, ABI, CA) and the following primers:
CTSK 
Western blotting
Cells were harvested and lysed with lysis buffer (Cell Signaling Technology, MA). Cell lysates were subjected to SDS-PAGE, transferred to a polyvinylidene difluoride membrane, and immunoblotted with antibodies against phosphorylated or nonphosphorylated NF-κB, p38, ERK, JNK, and Akt. The membrane was stripped and reprobed with anti-β-actin antibody (Sigma-Aldrich, MO) to ensure equal protein loading. Secondary antibodies conjugated to horseradish peroxidase were used for detection, followed by enhanced chemiluminescence (Pierce Biotechnology, IL) and autoradiography.
Flow cytometry
Cells were stained with phycoerythrin-conjugated RANK antibody (eBioscience, CA) after Fc blocking and analyzed with a FACSCalibur flow cytometer.
Identification of cytokines in culture medium by a cytokine array and ELISA
The supernatants (as conditioned medium) were collected from cultures of MM cells alone or BMSCs alone or cocultures of MM cells and BMSCs together in serum-free RPMI 1640 medium for 24 hours. The array (Raybio Human Cytokine Array 3 kit; RayBiotech, GA) was incubated with conditioned medium. Protein spots were detected and quantified by autoradiography according to the manufacturer's instructions. The value of the scans was adjusted on the basis of the intensity of positive control spots on each membrane by using MultiGauge V3.0 software (Fujifilm, Japan).
In addition, cytokine levels in conditioned medium were measured by a quantitative enzyme-linked immunosorbent assay (ELISA) kit (Bethyl Laboratories, TX) according to the manufacturer's instructions.
Statistical analysis
Experimental values are expressed as means ± standard errors of the means unless indicated otherwise. Statistical significance was analyzed with SPSS 10.0 software using unpaired Student's t-tests and one-way analysis of variance. A P value ≤ 0.05 was considered statistically significant. All results were reproduced in at least three independent experiments.
Results
MM cells have an inhibitory effect on OC formation from monocytes
Previous studies showed that RANKL, an activator of osteoclastogenesis, enhances OC differentiation and activity in vitro [22] , and MM cells produce RANKL [23] [24] [25] . In lines with previous results, without RANKL, few preOCs or monocytes could differentiate into mature OCs (Figure 1A, 1B) . In the presence of RANKL, CD14 + monocytes, the progenitors of OCs, develop into preOCs in a 7-day culture. PreOCs further develop into mature OCs with RANKL after additional 7 days of culturing. In addition, cocultures of MM cells without RANKL induced mature OC formation from preOCs, and with presence of RANKL OC differentiation is further enhanced, in lines with previous studies [26] . Interestingly, if monocytes were cocultured with MM cells in the presence of RANKL ( Figure  S1A) , the generation of mature OCs was partly inhibited ( Figure 1B In addition, we examined signaling pathways in monocytes during OC differentiation. We focused on NF-κB, PI3K/Akt, ERK, JNK, and p38 MAPK, because these signaling pathways are important for RANKL-induced OC differentiation [27, 28] . As shown in Figure 2C , addition of RANKL upregulated the levels of phosphorylated NF-κB, JNK, ERK and p38 MAPK but not Akt. However, cocultures of ARP-1 or MM.1S cells significantly repressed kinase phosphorylation ( Figure 2C ). The levels of nonphosphorylated kinases (data not shown) and β-actin protein were unchanged. There are several hallmarks of transcription factors for OC differentiation, such as c-fos, NFATc1, and PU.1, and their relative expression levels were evaluated by real-time PCR. In our system, NFATc1 expression played a major role in RANKL-mediated OC differentiation, and its level was greatly reduced in the presence of APR-1, MM.1S, RPMI-8266, or U266 cells as shown in Figure 2D , indicating a repressed OC differentiation by MM cells.
To assess whether the decrease in OC formation in cocultures of MM cells was accompanied by a decrease in OC bone resorption activity, we measured the levels of TRAP 5b activity, which reflects OC-induced bone resorption activity, in the same experimental settings as described above. The addition of RANKL induced high levels of TRAP 5b activity, while cocultures with MM cells, including primary MM cells from 10 MM patients ( Figure 2E ) and 6 MM cell lines ( Figure 2F ), significantly downregulated TRAP 5b activity. These results strongly suggest that MM cells inhibit RANKL-induced mature OC formation from monocytes.
MM cells produce cytokines that inhibit osteoclastogenesis
To examine whether MM cells induce OC inhibition via MM cell-monocyte interaction or via MM cell-produced soluble cytokines, we used a transwell coculture system ( Figure S1B ) that disrupts MM cell-monocyte interaction but does not affect MM cell growth or the ability of MM cells to produce and release cytokines. Monocytes were seeded in culture wells and MM cells were seeded in transwell inserts in the medium with or without RANKL [29] . Transwell cocultures of monocytes with ARP-1 or MM.1S cells (Figure 3A) or other MM cells (data not shown) retained the ability to inhibit OCs. The addition of conditioned medium, collected from cultures of ARP-1 or MM. 1S cells (Figure 3A) or other MM cells (data not shown), produced similar results.
We next sought to determine which soluble cytokines produced by MM cells play a role in OC inhibition. Conditioned media of ARP-1 cells and media with no cell cultures were collected. An array containing specific antibodies for 48 cytokines or chemokines, the majority of which are known regulators of osteoclastogenesis, was incubated with these media. As shown in Figure 3B and 3C, the levels of eight cytokines were higher in ARP-1-conditioned medium than those in medium containing no cell cultures. Reverse transcription PCR confirmed the array results and further showed that the mRNA levels of IL-8, IL-10, MCP-1, IFN-γ, thrombopoietin and angiogenin but not VEGF, RANTES, were expressed in the majority of primary MM cells and MM cell lines MCP-1 (data not shown), inhibited RANKL-induced OC formation from monocytes, indicating that MM cells express and secrete several cytokines that inhibit OC differentiation.
On the basis of these results, we focused on IL-10 and IL-8 to further verify the role and mechanism of MM-produced cytokines in MM-induced OC inhibition. We collected conditioned media of ARP-1 and U266 cells because ARP-1 cells secreted high, but U266 cells secreted low levels of IL-10, and both cell types secreted similar low levels of IL-8 ( Figure  4C ). The conditioned media and RANKL were added to cultures of monocytes. Our results showed that the addition of ARP-1-conditioned medium had a greater effect on OC inhibition than the addition of U266-conditioned medium did ( Figure 4D) . Furthermore, addition of recombinant IL-10, but not IL-8, to cultures of monocytes in medium containing RANKL inhibited mature OC formation ( Figure 3E) . Addition of neutralizing antibodies against IL-10 to cultures of monocytes with ARP-1-conditioned medium and RANKL significantly enhanced OC formation, while addition of anti-IL-8 antibodies or control IgG had no such effect ( Figure 4E) . Similar results were obtained with the addition of conditioned media of other MM cell lines and primary MM cells (data not shown).
Previous studies showed that STAT3 signaling pathway is activated by many inflammatory cytokines and plays a critical role in regulation of osteoclastogenesis [28] . We thus hypothesized that MM-derived cytokines such as IL-10 activates STAT3 and inhibits OC differentiation. Our results showed that addition of ARP-1-conditioned medium or recombinant IL-10 to cultures of monocytes significantly upregulated the phosphorylation of STAT3 ( Figure 5A) and downregulated phosphorylation of NF-κB ( Figure 5B) . However, addition of neutralizing antibodies against IL-10, but not control IgG, to cultures of monocytes with ARP-1-conditioned medium reduced STAT3 phosphorylation ( Figure  5A) . Furthermore, addition of low doses of STAT3 inhibitors significantly enhanced OC gene expression ( Figure 5C ) and 
BMSC-derived MCP-1 reverses MM-induced OC inhibition
As nonmalignant BMSCs play an important role in osteoclastogenesis, we examined whether BMSCs have a role in MM-induced OC inhibition. To mimic the bone marrow microenvironment, we used a coculture system in which monocytes were seeded on culture wells, and BMSCs and MM cells, alone or together, were seeded in transwell inserts in medium with or without RANKL ( Figure S1C ). BMSCs were generated from the bone marrow aspirates of MM patients or + OCs generated from cocultures of monocytes with ARP-1 cells were lower than those generated from cocultures of monocytes with U266 cells (with the addition of RANKL for both), as determined by TRAP staining. (E) The numbers of multinuclear TRAP + OCs generated from cultures of monocytes with the addition of RANKL and recombinant IL-10, but not IL-8, were significantly lower than those generated from cultures with the addition of RANKL only, as determined by TRAP staining. The numbers of multinuclear TRAP + OCs generated from cultures of monocytes in medium containing RANKL, ARP-1-conditioned medium (CM), and neutralizing antibodies against IL-10 (αIL-10) but not IL-8 (αIL-8), were higher than those generated from the control cultures containing control IgG (Ctrl IgG). Representative results from five independent experiments are shown. *P ≤ 0.05; **P ≤ 0.01. Furthermore, we hypothesized that soluble cytokines secreted from BMSCs might abrogate MM-induced OC inhibition. We collected conditioned media of BMSCs cultured alone, ARP-1 cells cultured alone, and BMSCs and ARP-1 cells cultured together. The media with no cell cultures served as a control. The cytokine array described above was applied. Our results showed that BMSCs secreted large amounts of cytokines into the medium (Figure 3D and 3E) . Of these cytokines, MCP-1 was produced at a high level in the conditioned medium of BMSCs cultured alone and was significantly upregulated in the conditioned medium of BMSCs and ARP-1 cells cultured together (Figure 3D and 3E) . ELISA further confirmed the array results and showed that all monocytes (Figure S3 ), BMSCs and ARP-1 cells (Figure 6C ) secreted MCP-1 with different levels, and addition of RANKL increased MCP-1 from monocytes ( Figure S3) , while in the presence of both BMSCs and ARP-1 cells, MCP-1 levels increased more than 5-fold, which was much higher than that of the cells alone ( Figure 6C) . To examine the role of MCP-1 in OC activation, neutralizing antibodies against MCP-1 were added to cocultures of monocytes with MM cells and BMSCs in medium with RANKL. We observed that the addition of antibodies against MCP-1, but not control IgG, significantly reduced OC differentiation ( Figure 6D ) and OC gene expression ( Figure 6E) . These results indicate that the upregulation of MCP-1 production from BMSCs reverses MMinduced OC inhibition.
Regulation of RANK expression by MM-derived IL-10 and BMSC-derived MCP-1 affects osteoclastogenesis
As RANKL binds to its receptor RANK on the progenitors of OCs and activates OC differentiation-associated signaling pathways, we wondered whether the expression of RANK in monocytes is regulated by MM-derived cytokines such as IL-10 and BMSC-derived MCP-1. Quantitative real-time PCR and flow cytometry showed that addition of recombinant IL-10 significantly downregulated mRNA ( Figure 7A ) and surface protein ( Figure 7B ) levels of RANK in monocytes in a dosedependent manner. Furthermore, addition of conditioned media of ARP-1 or MM.1S cells reduced surface RANK expression, while addition of anti-IL-10 antibody, but not control IgG, to Enhanced osteoclastogenesis and progressive bonedestructive lesions occur during MM cell growth in bone marrow. Previous studies showed that MM cells enhance osteoclastogenesis in vitro and in vivo. Yaccoby et al reported that MM cells upregulate mature OC formation from preOCs generated from monocytes in a 2-4 day coculture in medium with the addition of RANKL, M-CSF, and dexamethasone [26] . Other studies showed that cocultures of preOCs with MM cells induce OC formation in either the presence or the absence of BMSCs [19] Previous studies showed that RANKL plays a central role in OC activation. Addition of RANKL has been shown to induce OC differentiation and bone resorption activity in vitro [30, 31] . BMSCs, osteoblasts and activated T cells express and release RANKL to the bone marrow microenvironment [32, 33] . Moreover, MM cells stimulate BMSC production and release of RANKL and other cytokines, such as MIP-1α, VEGF, TNFα, MCP-1, stromal cell-derived factor-1, IL-3, and IL-7, into the bone marrow microenvironment, and in turn these cytokines enhance OC differentiation and activity in a RANKL-dependent or -independent manner [34] [35] [36] . BTK inhibitor PCI-32765 has been shown to be able to block RANKL/M-CSF-induced phosphorylation of Btk and downstream PLC-γ2 in OCs, and diminish TRAP 5b and bone resorption activity [37] . In addition, MM cells also produced multiple cytokines that involve in OC activation, such as PTHrP. Elevated levels of PTHrP were reported in a number of clinical myeloma cases, and recent studies by Cafforio et al. have found that both the full-length molecule and NH 2 -terminal fragment of PTHrP reinforces the production of osteoclastogenic factors RANKL and MCP-1, thus activate osteoclastogenesis [38] . On the other hand, several cytokines play a negative role in osteoclastogenesis. For example, OPG has been shown to disrupt RANKL-induced OC activation [39] . In patients, production of OPG from BMSCs is reduced by MM cells [40] . Our studies identified several OCinhibitory cytokines expressed and secreted by MM cells, such as IL-10, angiogenin, and thrombopoietin, which inhibited osteoclastogenesis. Antibodies against these cytokines enhanced OC formation. These findings indicate that MM cells express and secrete both stimulatory cytokines such as RANKL and inhibitory cytokines such as IL-10, angiogenin, and thrombopoietin, which work in a complementary manner in regulating osteoclastogenesis in bone marrow.
IL-10 is an inflammatory cytokine involved in immunosuppression [41] . Previous studies showed that IL-10 stimulates RANKL production from BMSCs in vitro and activates osteoclastogenesis in vivo [42] . However, IL-10 upregulates STAT3 and downregulates NF-κB, leading to OC inhibition [43] . Our results showed that all tested MM cell lines and primary MM cells from MM patients produced high levels of IL-10. Addition of anti-IL-10 antibody enhanced OC formation in cocultures of monocytes with MM cells via STAT3 activation. Furthermore, our study elucidates a novel mechanism that MMderived IL-10 inhibited RANKL-induced OC differentiation from monocytes by downregulating RANK expression. These results indicate that there is a feedback loop in IL-10-induced osteoclastogenesis, in which IL-10 upregulates RANKL production, but downregulates RANK expression and inhibits RANKL-induced OC differentiation and activity.
MCP-1 is a chemokine that recruits monocytes, T cells, and dendritic cells to sites of infection or tissue injury. Previous studies have shown that MCP-1 promotes the fusion of hematopoietic precursors to mature OCs [44] , rescues granulocyte macrophage colony-stimulating factor-induced OC inhibition [44] , and determines OC activity by binding to receptor CCR2 [45] . MCP-1 can be secreted from monocytes [44] and BMSCs [46] , and its levels are upregulated by RANKL during osteoclastogenesis [44, 47] . Moreover, we previously found that MM cells also secreted low levels of MCP-1, and MM-derived MCP-1 involved in OC differentiation [20] . ELISA results showed that MM cells ARP-1 produced around 500 pg/ml of MCP-1in cultured media. However, we also observed that in the presence of both BMSCs and ARP-1 cells, the levels of MCP-1 in cultured media increased more than 5-fold, which is much higher than that of ARP-1 cells alone or BMSC alone, indicating a synergistic effect from the combination presence of BMSCs and MM cells. Monocytes secret MCP-1 and RANKL stimulates monocyte secretion of MCP-1. The levels of secreted MCP-1 were examined with ELISA. Cultured CD14 + monocytes were isolated from the PBMCs by using anti-CD14 antibody-coated magnetic beads and were incubated with or without (Medium) 50ng/ml of RANKL for 24 hours. ELISA showed that monocytes secret MCP-1 and the MCP-1 level was higher in medium of cultured monocytes with RANKL than those of monocytes without RANKL.
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